Axon Lab AG partners with bioMérieux

Axon Lab AG, a leader in medical diagnostics, life sciences and software solutions, headquartered in Baden Switzerland formalises its partnership for the distribution of the life science solutions from bioMérieux within Switzerland.

Since 2022, the bioMérieux research and development department has developed and designed new fully automated solutions for the study of cellular immunity. These tests, implemented on VIDAS® instruments, are intended for academic and clinical research under RUO (Research Use Only). These products complement Axonlab's current offering and strengthen its commitment to clinical research.

Immunity is impaired in patients during sepsis, cancer and organ transplantation. These research solutions from bioMérieux allow the monitoring of the immune status of the patient with very little hands on time in the lab (Cytokine 2023 Jun 18;169:).

A trusted partner for laboratories in Switzerland, Axonlab has always been keen to continue its development in the life sciences sector by providing innovative solutions. Its partnership with bioMérieux is a continuation of this approach offering its customers standardised solutions to simplify and automate their research.